全球數位病理市場規模、佔有率、趨勢和成長分析報告（2026-2034）

數位病理市場預計將從 2025 年的 13 億美元成長到 2034 年的 27.7 億美元，2026 年至 2034 年的複合年成長率為 8.71%。

隨著醫療機構採用數位化技術進行檢體分析，全球數位病理市場正迅速成長。數位病理技術能夠掃描傳統的病理切片，並將其轉換為高解析度的數位影像，從而實現電子化的查看、分析和共用。這項技術提高了診斷準確率，並促進了病理學家之間更有效率的協作。

多種因素正在推動數位病理市場的成長。對更快、更準確的疾病診斷日益成長的需求促使醫療機構採用數位影像解決方案。此外，影像分析軟體和人工智慧的進步也提高了檢測組織檢體異常的能力。

隨著醫療保健系統不斷推動數位化轉型，數位病理市場預計將持續擴張。與人工智慧和數據分析的融合有望進一步提升診斷效率和研究能力。隨著精準醫療和先進診斷需求的成長，數位病理將在現代醫學中發揮日益重要的作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球數位病理市場：依產品分類

• 市場分析、洞察與預測
• 軟體
• 裝置
• 儲存系統

第5章：全球數位病理市場：按類型分類

• 市場分析、洞察與預測
• 人類病理學
• 獸醫病理學

第6章：全球數位病理市場：依應用分類

• 市場分析、洞察與預測
• 藥物發現與開發
• 學術研究
• 疾病診斷

第7章：全球數位病理市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 生物技術和製藥公司
• 診斷檢查室
• 學術研究機構

第8章 全球數位病理市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Leica Biosystems Nussloch GmbH（Danaher Corporation）
  • Koninklijke Philips NV
  • F. Hoffmann La Roche Ltd
  • Olympus Corporation
  • Agfa Gevaert NV
  • Sectra AB
  • Hamamatsu Photonics KK
  • Cisco Systems Inc
  • Masimo Corporation
  • McKesson Medical Surgical Inc
  • GE HealthCare Technologies Inc
  • Oracle Corporation（Cerner）
  • ContextVision AB
  • CellaVision AB
  • InspiraA,ATa Inc

The Digital Pathology Market size is expected to reach USD 2.77 Billion in 2034 from USD 1.30 Billion (2025) growing at a CAGR of 8.71% during 2026-2034.

The global digital pathology market has grown rapidly as healthcare institutions adopt digital technologies for analyzing medical samples. Digital pathology involves scanning traditional pathology slides and converting them into high-resolution digital images that can be viewed, analyzed, and shared electronically. This technology improves diagnostic accuracy and allows pathologists to collaborate more efficiently.

Several factors are driving the growth of the digital pathology market. Increasing demand for faster and more accurate disease diagnosis has encouraged healthcare providers to adopt digital imaging solutions. Additionally, advances in image analysis software and artificial intelligence have enhanced the ability to detect abnormalities in tissue samples.

Looking ahead, the digital pathology market is expected to expand as healthcare systems continue embracing digital transformation. Integration with artificial intelligence and data analytics may further improve diagnostic efficiency and research capabilities. As demand for precision medicine and advanced diagnostics grows, digital pathology will play an increasingly important role in modern healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Software
• Device
• Storage System

By Type

• Human Pathology
• Veterinary Pathology

By Application

• Drug Discovery & Development
• Academic Research
• Disease Diagnosis

By End Use

• Hospitals
• Biotech & Pharma Companies
• Diagnostic Labs
• Academic & Research Institutes

COMPANIES PROFILED

• Leica Biosystems Nussloch GmbH Danaher Corporation, Koninklijke Philips NV, F Hoffmann La Roche Ltd, Olympus Corporation, Agfa Gevaert NV, Sectra AB, Hamamatsu Photonics KK, Cisco Systems Inc, Masimo Corporation, McKesson Medical Surgical Inc, GE HealthCare Technologies Inc, Oracle Corporation Cerner, ContextVision AB, CellaVision AB, Inspirata Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIGITAL PATHOLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Storage System Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIGITAL PATHOLOGY MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Human Pathology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Veterinary Pathology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIGITAL PATHOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Disease Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DIGITAL PATHOLOGY MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Biotech & Pharma Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diagnostic Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DIGITAL PATHOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Type
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Type
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Type
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Type
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Type
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL DIGITAL PATHOLOGY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Leica Biosystems Nussloch GmbH (Danaher Corporation)
  • 10.2.2 Koninklijke Philips N.V
  • 10.2.3 F. Hoffmann La Roche Ltd
  • 10.2.4 Olympus Corporation
  • 10.2.5 Agfa Gevaert N.V
  • 10.2.6 Sectra AB
  • 10.2.7 Hamamatsu Photonics K.K
  • 10.2.8 Cisco Systems Inc
  • 10.2.9 Masimo Corporation
  • 10.2.10 McKesson Medical Surgical Inc
  • 10.2.11 GE HealthCare Technologies Inc
  • 10.2.12 Oracle Corporation (Cerner)
  • 10.2.13 ContextVision AB
  • 10.2.14 CellaVision AB
  • 10.2.15 InspiraA,ATa Inc